Cargando…
Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials
Heart failure (HF) is a global pandemic with increasing prevalence and mortality rates annually. Its main cause is myocardial infarction (MI), followed by rapid cardiac remodeling. Several clinical studies have shown that probiotics can improve the quality of life and reduce cardiovascular risk fact...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393865/ https://www.ncbi.nlm.nih.gov/pubmed/37349622 http://dx.doi.org/10.1007/s12602-023-10105-2 |
_version_ | 1785083239283556352 |
---|---|
author | Taslim, Nurpudji Astuti Yusuf, Muhammad Ambari, Ade Meidian Del Rosario Puling, Imke Maria Ibrahim, Filzatuz Zahro Hardinsyah, Hardinsyah Kurniawan, Rudy Gunawan, William Ben Mayulu, Nelly Joseph, Victor F. F. Sabrina, Nindy Rizal, Mochammad Tallei, Trina Ekawati Kim, Bonglee Tsopmo, Apollinaire Nurkolis, Fahrul |
author_facet | Taslim, Nurpudji Astuti Yusuf, Muhammad Ambari, Ade Meidian Del Rosario Puling, Imke Maria Ibrahim, Filzatuz Zahro Hardinsyah, Hardinsyah Kurniawan, Rudy Gunawan, William Ben Mayulu, Nelly Joseph, Victor F. F. Sabrina, Nindy Rizal, Mochammad Tallei, Trina Ekawati Kim, Bonglee Tsopmo, Apollinaire Nurkolis, Fahrul |
author_sort | Taslim, Nurpudji Astuti |
collection | PubMed |
description | Heart failure (HF) is a global pandemic with increasing prevalence and mortality rates annually. Its main cause is myocardial infarction (MI), followed by rapid cardiac remodeling. Several clinical studies have shown that probiotics can improve the quality of life and reduce cardiovascular risk factors. This systematic review and meta-analysis aimed to investigate the effectiveness of probiotics in preventing HF caused by a MI according to a prospectively registered protocol (PROSPERO: CRD42023388870). Four independent evaluators independently extracted the data using predefined extraction forms and evaluated the eligibility and accuracy of the studies. A total of six studies consisting of 366 participants were included in the systematic review. Probiotics are not significant in intervening left ventricular ejection fraction (LVEF) and high-sensitivity C-reactive protein (hs-CRP) when compared between the intervention group and the control group due to inadequate studies supporting its efficacy. Among sarcopenia indexes, hand grip strength (HGS) showed robust correlations with the Wnt biomarkers (p < 0.05), improved short physical performance battery (SPPB) scores were also strongly correlated with Dickkopf-related protein (Dkk)-3, followed by Dkk-1, and sterol regulatory element-binding protein 1 (SREBP-1) (p < 0.05). The probiotic group showed improvement in total cholesterol (p = 0.01) and uric acid (p = 0.014) compared to the baseline. Finally, probiotic supplements may be an anti-inflammatory, antioxidant, metabolic, and intestinal microbiota modulator in cardiac remodeling conditions. Probiotics have great potential to attenuate cardiac remodeling in HF or post-MI patients while also enhancing the Wnt signaling pathway which can improve sarcopenia under such conditions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12602-023-10105-2. |
format | Online Article Text |
id | pubmed-10393865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-103938652023-08-03 Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials Taslim, Nurpudji Astuti Yusuf, Muhammad Ambari, Ade Meidian Del Rosario Puling, Imke Maria Ibrahim, Filzatuz Zahro Hardinsyah, Hardinsyah Kurniawan, Rudy Gunawan, William Ben Mayulu, Nelly Joseph, Victor F. F. Sabrina, Nindy Rizal, Mochammad Tallei, Trina Ekawati Kim, Bonglee Tsopmo, Apollinaire Nurkolis, Fahrul Probiotics Antimicrob Proteins Research Heart failure (HF) is a global pandemic with increasing prevalence and mortality rates annually. Its main cause is myocardial infarction (MI), followed by rapid cardiac remodeling. Several clinical studies have shown that probiotics can improve the quality of life and reduce cardiovascular risk factors. This systematic review and meta-analysis aimed to investigate the effectiveness of probiotics in preventing HF caused by a MI according to a prospectively registered protocol (PROSPERO: CRD42023388870). Four independent evaluators independently extracted the data using predefined extraction forms and evaluated the eligibility and accuracy of the studies. A total of six studies consisting of 366 participants were included in the systematic review. Probiotics are not significant in intervening left ventricular ejection fraction (LVEF) and high-sensitivity C-reactive protein (hs-CRP) when compared between the intervention group and the control group due to inadequate studies supporting its efficacy. Among sarcopenia indexes, hand grip strength (HGS) showed robust correlations with the Wnt biomarkers (p < 0.05), improved short physical performance battery (SPPB) scores were also strongly correlated with Dickkopf-related protein (Dkk)-3, followed by Dkk-1, and sterol regulatory element-binding protein 1 (SREBP-1) (p < 0.05). The probiotic group showed improvement in total cholesterol (p = 0.01) and uric acid (p = 0.014) compared to the baseline. Finally, probiotic supplements may be an anti-inflammatory, antioxidant, metabolic, and intestinal microbiota modulator in cardiac remodeling conditions. Probiotics have great potential to attenuate cardiac remodeling in HF or post-MI patients while also enhancing the Wnt signaling pathway which can improve sarcopenia under such conditions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12602-023-10105-2. Springer US 2023-06-22 2023 /pmc/articles/PMC10393865/ /pubmed/37349622 http://dx.doi.org/10.1007/s12602-023-10105-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Taslim, Nurpudji Astuti Yusuf, Muhammad Ambari, Ade Meidian Del Rosario Puling, Imke Maria Ibrahim, Filzatuz Zahro Hardinsyah, Hardinsyah Kurniawan, Rudy Gunawan, William Ben Mayulu, Nelly Joseph, Victor F. F. Sabrina, Nindy Rizal, Mochammad Tallei, Trina Ekawati Kim, Bonglee Tsopmo, Apollinaire Nurkolis, Fahrul Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials |
title | Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials |
title_full | Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials |
title_fullStr | Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials |
title_full_unstemmed | Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials |
title_short | Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials |
title_sort | anti-inflammatory, antioxidant, metabolic and gut microbiota modulation activities of probiotic in cardiac remodeling condition: evidence from systematic study and meta-analysis of randomized controlled trials |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393865/ https://www.ncbi.nlm.nih.gov/pubmed/37349622 http://dx.doi.org/10.1007/s12602-023-10105-2 |
work_keys_str_mv | AT taslimnurpudjiastuti antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials AT yusufmuhammad antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials AT ambariademeidian antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials AT delrosariopulingimkemaria antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials AT ibrahimfilzatuzzahro antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials AT hardinsyahhardinsyah antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials AT kurniawanrudy antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials AT gunawanwilliamben antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials AT mayulunelly antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials AT josephvictorff antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials AT sabrinanindy antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials AT rizalmochammad antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials AT talleitrinaekawati antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials AT kimbonglee antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials AT tsopmoapollinaire antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials AT nurkolisfahrul antiinflammatoryantioxidantmetabolicandgutmicrobiotamodulationactivitiesofprobioticincardiacremodelingconditionevidencefromsystematicstudyandmetaanalysisofrandomizedcontrolledtrials |